Samarth Kulkarni, the Chief Executive Officer of $CRSP, sold 4,242 shares of the company on 10-14-2025 for an estimated $282,517. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.0% of their shares of this class of stock. Following this trade, they now own 205,096 shares of this class of $CRSP stock.
$CRSP Insider Trading Activity
$CRSP insiders have traded $CRSP stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:
- SIMEON GEORGE has made 3 purchases buying 989,812 shares for an estimated $51,499,918 and 0 sales.
- DOUGLAS A TRECO purchased 20,000 shares for an estimated $1,140,600
- SAMARTH KULKARNI (Chief Executive Officer) has made 0 purchases and 2 sales selling 17,323 shares for an estimated $1,043,177.
- NAIMISH PATEL (Chief Medical Officer) sold 3,932 shares for an estimated $141,316
- JAMES R. KASINGER (General Counsel and Secretary) sold 1,076 shares for an estimated $71,661
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRSP Hedge Fund Activity
We have seen 213 institutional investors add shares of $CRSP stock to their portfolio, and 161 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,452,819 shares (+132.1%) to their portfolio in Q2 2025, for an estimated $167,945,116
- ORBIS ALLAN GRAY LTD added 1,201,600 shares (+76.9%) to their portfolio in Q2 2025, for an estimated $58,445,824
- GEODE CAPITAL MANAGEMENT, LLC added 1,025,979 shares (+98.1%) to their portfolio in Q2 2025, for an estimated $49,903,618
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 988,061 shares (-50.6%) from their portfolio in Q2 2025, for an estimated $48,059,287
- STATE STREET CORP added 859,334 shares (+35.6%) to their portfolio in Q2 2025, for an estimated $41,798,005
- MORGAN STANLEY removed 788,602 shares (-60.7%) from their portfolio in Q2 2025, for an estimated $38,357,601
- UBS GROUP AG added 771,685 shares (+37.2%) to their portfolio in Q2 2025, for an estimated $37,534,758
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRSP Analyst Ratings
Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 10/10/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/23/2025
- JP Morgan issued a "Overweight" rating on 09/18/2025
- Chardan Capital issued a "Buy" rating on 08/05/2025
- B of A Securities issued a "Buy" rating on 07/22/2025
- Piper Sandler issued a "Overweight" rating on 06/27/2025
- JMP Securities issued a "Market Outperform" rating on 06/27/2025
To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.
$CRSP Price Targets
Multiple analysts have issued price targets for $CRSP recently. We have seen 12 analysts offer price targets for $CRSP in the last 6 months, with a median target of $79.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $81.0 on 10/10/2025
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $80.0 on 09/23/2025
- Brian Cheng from JP Morgan set a target price of $70.0 on 09/18/2025
- Gena Wang from Barclays set a target price of $56.0 on 08/06/2025
- Luca Issi from RBC Capital set a target price of $42.0 on 08/05/2025
- Geulah Livshits from Chardan Capital set a target price of $82.0 on 08/05/2025
- Geoff Meacham from B of A Securities set a target price of $78.0 on 07/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
